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This work aimed to study the effect of direct injection of shark (Squalus acanthias L.) DNA into skeletal 
muscles of red tilapia (Oreochromis sp.) fed at different additive levels (two probiotic levels; 0.3 and 
0.5%, two amino yeast levels; 0.5 and 1.0% and a mixed of 0.3% probiotic and 0.5% amino yeast), on the 
productive performance. The results show that red tilapia injected with DNA had significant (P≤0.05) 
superiority of growth performance and feed utilization; besides the body composition was improved. In 
addition, the different levels of probiotic and amino yeast were more effective in stimulating most of the 
productive performance traits compared to the control group and the mixed of probiotic and amino 
yeast. The result indicates a possible easy and rapid way for improving red tilapia characteristics. 
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INTRODUCTION 
 
A quick method and rapid way for introducing foreign 
DNA injected directly into the muscle tissue was reported 
by Wolff et al. (1990) and Ono et al. (1990) in adult mice, 
by Thomson and Booth (1990) in rat and by Hansen et al. 
(1991), Rahman and Maclean (1992), Tan and Chan 
(1997), Xu et al. (1999), El-Zaeem (2004), Hemeida et al. 
(2004), El-Zaeem and Assem (2004), Assem and El-
Zaeem (2005), El-Zaeem (2012), and El-Zaeem et al. 
(2012) in fish. This procedure is useful because muscle 
injection is much easier than  the  others  and  very  rapid  
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results are obtained (Rahman and Maclean, 1992). The 
foreign DNA was presented extrachromosomally up to six 
months following injection (Wolff et al., 1990). Moreover, 
Sudha et al. (2001) reported that the expression of 
muscular injection of DNA was evident in several non 
muscle tissues, such as skin epithelia, pigment cells, 
blood vessel cells and neuron-like cells. 
A series studies have focused on the use of shark DNA 
to boost immune responses in fish (El-Zaeem and 
Assem, 2004; Assem and El-Zaeem, 2005). Sharks 
contain high levels of immunoglobulin (IgM) proteins, 
which act as antibodies and help initiate immune respon-
ses to bacterial invasions. Although IgM can be found at 
high levels in shark (up to 50% of the serum proteins), it 
has been reported to be present at much lower levels in 
fish   such   as   Atlantic   salmon,  Halibut  (Hippoglossus  
 
 
 
 
hippoglosus L.), Haddock (Melanogrammus aeglefinus 
L.) and Cod (Gadus morhua L.) (2, 8, 13 and 20% of the 
serum proteins, respectively) (Marchalonis et al., 1993; 
Magnadottir, 1998). When shark (Squalus acanthias L.) 
DNA was injected into the skeletal muscles of Nile tilapia 
(Oreochromis niloticus) and red belly tilapia (Tilapia zillii) 
fingerlings, fish showed significantly higher levels of total 
antibody activity, serum total protein, and globulin (El-
Zaeem and Assem, 2004; Assem and El-Zaeem, 2005). 
In addition, injected tilapia had significant growth 
enhancement and changes in proximate composition, 
with decreases in moisture and increases in both protein 
and lipid content. Injected fish showed high genetic 
polymorphism, indicating random integration of the shark 
genes into tilapia muscle DNA.   
Since the first use of probiotics in aquaculture, a 
growing number of studies have demonstrated their 
ability to control potential pathogens and to increase the 
growth rates and welfare of farmed aquatic animals 
(Gatesoupe, 1991, 1999; Wang et al., 2005; Wang and 
Xu, 2006; Wang, 2007). The beneficial effects of pro-
biotics, such as improvement of feed utilization, modu-
lation of intestinal microflora, enhancement of immune 
responses and antagonism to pathogens, have been 
demonstrated in a number of previous studies (Balcázar 
et al., 2006a,b; Irianto and Austin, 2002a,b; Kesarcodi-
Watson et al., 2008; Merrifield et al., 2010a,b,c,d; Wang 
et al., 2008). Among the various benefits of probiotics, 
immunomodulatory activity is noteworthy in improving the 
overall health status of the host. However, there is limited 
research available for immunomodulatory activity of 
probiotics, especially for the long-term use of probiotics in 
fish diets. The most commonly used probiotics in 
aquaculture practices belong to lactic acid bacteria and 
Bacillus spp. (Wang et al., 2008). 
Brewer's yeast, Saccharomyces cerevisiae, can be 
used as a probiotic (Chiu et al., 2010; Lara-Flores et al., 
2003) and also as growth promoter (Abdel-Tawwab et al., 
2008; Lara-Flores et al., 2003; Li and Gatlin, 2003, 2005) 
in aquaculture. Brewer's yeast (S. cerevisiae) has been 
used as a feed supplement for various animals. It 
contains various immunostimulating compounds such as 
β-glucans, nucleic acids, mannan oligosaccharides and 
other cell wall components (Li and Gatlin, 2003, 2005; 
Oliva-Teles and Gonçalves, 2001). It has been observed 
that S. cerevisiae can positively influence the non-specific 
immune responses (Ortuno et al., 2002; Siwicki et al., 
1994) as well as growth performance (Abdel-Tawwab et 
al., 2008; Li and Gatlin, 2003, 2005; Noh et al., 1994; 
Oliva-Teles and Gonçalves, 2001; Rumsey et al., 1991; 
Taoka et al., 2006) of some fish species. 
Therefore, the objective of this study was to evaluate 
the productive performance characteristics of red tilapia 
(Oreochromis sp.) injected with shark (Squalus acanthias 
L.) DNA (into skeletal muscles) and fed maintained diets 
containing different additive levels of probiotic and amino 
yeast. 
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MATERIALS AND METHODS 
 
Fish origin 
 
The red tilapia, Oreochromis sp. fry used in this study was a hybrid, 
descended of an original cross of female Oreochromis 
mossambicus x male O. niloticus and obtained from Marine Fish 
Hatchery, 21 Km, Alexandria, Egypt. Red tilapias were transported 
to the laboratory of Breeding and Production of Fish, Animal and 
Fish Production Department, Faculty of Agriculture (Saba-Bacha), 
Alexandria University, Alexandria, Egypt.  
 
 
DNA extraction  
 
High molecular weight DNA was extracted according to Brem et al. 
(1988) method. Isolation of DNA was accomplished by reducing 
liver sample from shark (Squalus acanthias L.) to small pieces, 
which were then transferred to a microfuge tube and incubated 
overnight until the sample was digested in a buffer solution 
containing 50 mM Tris, 100 mM ethylenediaminetertracetic acid 
(EDTA, pH 8.0), 100 mM NaCl, 0.1% sodium dodecyl sulfate (SDS) 
and 0.5 mg/ml proteinase K. After incubation, samples were 
extracted twice for 15 to 20 min with one volume of phenol/ 
chloroform (1:1) and then again twice for 15 min with one volume of 
chloroform/isoamyle-alcohol (24:1). The aqueous phase was then 
precipitated with 2.5 volumes of 100% ethanol in the presence of 
1/10 volume 3 M sodium acetate (pH 6.0). The pelleted DNA was 
washed with 70% ethanol and dissolved in 0.1x saline sodium 
citrate (SSC) buffer. The DNA concentrations were measured by 
UV spectrophotometry. The extracted DNA was restricted by Eco 
R1 restriction enzyme type II. It digested DNA between guanine 
and adenine according to Tsai et al. (1993). 
 
 
Experimental design 
 
Culture condition 
 
Red tilapias were acclimatized to laboratory conditions for two 
weeks. Fry with an initial body weight (2.9±0.11 g) were divided 
randomly to 12 groups and three replicates for each group, stocked 
at the rate of 10 fish per aquarium. The aquaria of dimensions 100 
x 34 x 50 cm were supplemented with continuous aeration. Nearly 
half of the volume of water in the aquaria was changed daily by 
freshly stocked tap water and the aquaria were cleaned every day 
before feeding. Water temperature was maintained at 26°C by 
means of electric aquarium heaters. Fish were stocked at 1.0 
fish/10 L and fed twice daily to satiation, six days a week. Fish were 
weighed at the beginning of experiment and then biweekly for eight 
weeks.  
 
 
Injection of foreign DNA in vivo  
 
The DNA concentration of 40 µg/0.1 ml/fish (El-Zaeem, 2004; El-
Zaeem and Assem, 2004; Hemeida et al., 2004; Assem and El-
Zaeem, 2005) were prepared using 0.1x SSC buffer and injected 
into red tilapia muscles using a hypodermic needle. The injection 
was applied on six groups of red tilapia fingerlings, while the other 
six groups were left without injection as a control. 
 
 
Diets formulation and preparation 
 
Six dietary treatments were tested in triplicate groups: the control 
diet with no dietary supplementation (C) and five other test diets 
which included; probiotic added at 0.3% (P1) and 0.5% (P2);  amino  
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Table 1. Composition and proximate analysis of red tilapia (Oreochromis sp.) diets used during the growth period. 
 
Ingredient C P1 P2 A1 A2 P1+A1 
Wheat flour 31 31 31 31 31 31 
Wheat bran 18 18 18 18 18 18 
Soybean meal 23 22.7 22.5 22.5 22 22.2 
Yellow corn 14.2 14.2 14.2 14.2 14.2 14.2 
Fish meal 11.5 11.5 11.5 11.5 11.5 11.5 
Bone meal 2 2 2 2 2 2 
Vit. & Min. Mix* 0.3 0.3 0.3 0.3 0.3 0.3 
Probiotic
1
 0 0.3 0.5 0 0 0.3 
Amino yeast
2
 0 0 0 0.5 1.0 0.5 
Total 100 100 100 100 100 100 
       
Proximate analysis (%)       
Moisture 10.63 10.73 10.71 10.83 10.96 10.78 
Protein 23.84 23.82 23.84 23.70 23.69 23.83 
Fat 7.31 7.30 7.29 7.29 7.21 7.24 
Fiber 4.24 4.20 4.21 4.13 4.02 4.19 
Nitrogen free extract (NFE) 44.07 44.07 44.04 44.18 44.30 44.10 
Ash 9.91 9.88 9.91 9.87 9.82 9.86 
Metabolizable energy (kcal/100g) 244.05 244.23 243.85 244.14 243.51 243.87 
 
* Content/kg of vitamin and minerals mixture (P- Fizer, Cairo, Egypt). Vitamin A, 4.8 MIU; Vitamin D, 0.8 MIU; Vitamin E, 4.0 g; vitamin K, 0.8 g; 
vitamin B1, 0.4 g; vitamin B2, 1.6 g; vitamin B6, 0.6 g; vitamin B7, 20.0 mg; vitamin B12, 4.0 g; folic acid, 0.4 g; nicotinic acid, 8.0 g; pantothenic acid, 
4.0 g; colin chloride, 200 g; zinc, 22 g; cooper, 4.0 g; iodine, 0.4 g; iron, 12.0 g; manganese, 22.0 g; selenium, 0.04 g. 
1
 Probiotic; produced by Pura 2A. Company, Cairo, Egypt, containing: Lactobacillus sp. (L. plantarum, L. fermentum, L. delbrueckii), Bacillus subtilis, 
Saccharomyces cerevisiae, Rhodopseudomonas  palustris  and especially active additives. probiotic 1%, molasses 3%, water 96%. 
2
 Amino yeast; produced by New Vetro vit 10 th. of Ramadan city, Egypt containing: B. Glucan 44.50 g, Rhammose (1500.00 mg), Xylose (3000.00 
mg), D L- Methionine (10110.00 mg), lysine (2600.00 mg), monnanollgo saccharides (200.00 g.) 
 
 
 
yeast added at 0.5% (A1) and 1.0% (A2); and mixed of probiotic 
and amino yeast 0.3% + 0.5% (P1+A1). Total protein content for all 
dietary treatments was adjusted by the parallel decrease of 
soybean meal with increase level of dietary supplementation as 
described in Table 1. Metabolizable energy was calculated accor-
ding to feedstuff values reported by NRC, (1993). Dry ingredients 
were passed through a sieve (0.6 mm diameter hole) before mixing 
into the diets. Mixtures were homogenized in a food grinder mixer. 
Water was then blended into the mixture at the ratio of 50% for 
pelleted. The diets were pelleted using meat grinder with a 1.5 mm 
diameter. 
 
  
Quantitative traits studied 
 
The following parameters were measured; body weight (BG), 
weight gain (WG), specific growth rate (SGR %/day), percent body 
weight increases (%BWI), feed intake, feed conversion ratio (FCR), 
protein efficiency ratio (PER), protein and energy retention percent 
(PR% and ER%). Initial and final whole body composition analyses 
were performed using the standard methods (AOAC, 1984) for 
moisture (oven drying), for protein (macro-kjeldahl method) and lipid 
(ether extract method).  
 
 
Statistical analysis 
 
Data were analyzed using the following model (CoStat, 1986): 
 
Yijkl=µ+Ti+Aj+(TA)ij+ Bk+eijk 
Where,Yijk is the observation of the ijk
th
 parameter measured; µ is 
the overall mean; Ti is the effect of i
th
 DNA; Aj is the effect of J
th
 
additives; (TA)ij is the interaction DNA by additives; Bk is the effect 
of K
th 
 block;  and eijk is the random error. 
 
Significant differences (P≤0.05) among means were tested by the 
method of Duncan (1955). 
 
 
RESULTS 
 
Data presented in Table 2 show that the final body weight 
(FBW), weight gain (WG), percent body weight increases 
(% BWI) and specific growth rate (SGR %/day) of red 
tilapia (Oreochromis sp.) injected with shark DNA were 
significantly higher (P≤0.05) than those of the non-
injected fish. Moreover, the highest value of FBW was 
obtained by the red tilapia fed the highest level of 
probiotic, but did not differ (P≤0.05) significantly from 
those fish fed the lowest level of probiotic and the lowest 
and highest levels of amino yeast. The highest WG was 
achieved by the fish fed the highest level of probiotic, but 
did not differ (P≤0.05) significantly from those of fish fed 
the lowest level of probiotic and the highest level of 
amino yeast. Red tilapia fed the lowest level of probiotic 
show higher mean of % BWI, but did not differ (P≤0.05) 
significantly from that  of  fish  fed  the  highest  level. The  
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Table 2. Effect of shark DNA injection and different additive levels on growth performance
1 
of red tilapia (Oreochromis 
sp.).    
 
Treatment IBW (g) FBW (g) WG (g) %BWI SGR %/day 
Type of DNA (T)      
DNA 2.92±0.10 14.87±1.76
a
 11.9±61.74
a
 409.97±59.84
 a
 2.90±0.20
a
 
Non-DNA 
 
2.83±0.11 12.81±0.81
b
 9.97±0.86
b
 353.04±39.41
b
 2.70±0.16
b
 
Type of Additive (A)      
Control 2.90±0.10 12.37±1.50
c
 9.48±0.16
c
 327.21±16.98
c
 2.59±0.06
d
 
P1 2.80±0.00 14.90±0.81
a
 12.10±0.81
a
 432.14±33.25
a
 2.98±0.10
a
 
P2 2.90±0.13 15.05±2.96
a
 12.15±3.32
a
 417.56±101.12
ab
 2.91±0.31
ab
 
A1 2.85±0.09 13.63±0.99
abc
 10.78±0.94
b
 378.06±33.51
bc
 2.84±0.09
abc
 
A2 2.90±0.10 13.93±1.20
ab
 11.03±1.10
ab
 379.34±29.21
bc
 2.77±0.12
bcd
 
P1+A1 2.90±0.10 13.16±0.77
bc
 10.26±0.81
bc
 354.70±40.57
c
 2.70±0.14
cd
 
      
Interactions T x A      
DNA x C 2.90±0.10 12.45±0.15
b
 9.55±0.05
b
 329.65±13.64 2.60±0.04 
DNA x P1 2.80±0.00 15.50±0.70
ab
 12.70±0.70
ab
 453.57±35.36 3.06 ±0.09 
DNA x P2 3.00±0.00 17.90±1.10
a
 14.90±1.10
a
 496.67±51.85 3.19±0.11 
DNA x A1 2.90±0.10 14.44±0.22
ab
 11.54±0.12
ab
 398.27±13.57 2.87±0.04 
DNA x A2 3.00±0.00 15.10±0.30
ab
 12.10±0.30
ab
 403.33±14.14 2.89±0.04 
DNA X P1+A1 2.90±0.00 13.86±0.10
b
 10.96±0.20
ab
 378.34±27.81 2.80±0.08 
Non-DNA x C 2.90±0.00 12.30±0.10
b
 9.40±0.20
b
 324.77±25.59 2.59±0.08 
Non-DNA x P1 2.90±0.00 14.30±0.30
ab
 11.50±0.30
ab
 410.72±15.15 2.91±0.02 
Non-DNA x P2 2.80±0.00 12.20±0.20
b
 9.40±0.40
b
 338.46±54.39 2.64±0.16 
Non-DNA x A1 2.80±0.20 12.82±0.78
b
 10.02±0.78
b
 357.86±39.39 2.82±0.12 
Non-DNA x A2 2.80±0.00 12.75±0.15
b
 9.95±0.15
b
 355.36±7.57 2.66±0.03 
Non-DNA X P1+A1 2.90±0.00 12.47±0.47
b
 9.57±0.57
b
 331.07±43.94 2.61±0.13 
 
(1) Mortality rate was 0.0% for all fish injected and for the control.  
Means having different superscripts within column in a main effect are significantly different (P≤0.05).P1 and P2, 0.3 and 
0.5% of probiotic, respectively; A1 and A2, 0.5 and 1.0 % of amino yeast, respectively. 
Initial and final body weight (IBW and FBW) = body weight at start and end of experiment. 
Weight gain (WG) = final weight - initial weight. 
Percent body weight increases (% BWI) = (final weight - initial weight) 100/ initial weight. 
Specific growth rate (SGR%/day) = (Ln final weight - Ln initial weight) 100 / number of days.  
 
 
 
highest value of SGR %/ day was recorded by red tilapia 
fed the lowest level of probiotic, but did not differ (P≤0.05) 
significantly from those of fish fed the highest level of 
probiotic and the lowest level of amino yeast.  
Moreover, the highest record of FBW was obtained by 
red tilapia injected with shark DNA and fed the highest 
level of probiotic, but did not differ (P≤0.05) significantly 
from those of fish injected with DNA and fed the lowest 
level probiotic, the lowest and the highest levels of amino 
yeast and non-injected fish fed the lowest level of 
probiotic. Weight gain of red tilapia injected with shark 
DNA and fed with the highest level of probiotic showed a 
higher mean, but this mean did not differ (P≤0.05) 
significantly from that of all injected fish except for the 
control group and non-injected red tilapia fed the lowest 
level of probiotic. 
At the end of the experiment, crude protein and crude 
fat of  red  tilapia  injected  with  shark  DNA were  signifi-
cantly (P≤0.05) higher than those of the non-injected 
group while, the moisture content decreased (P≤0.05) 
significantly by red tilapia injected with shark DNA. The 
highest records of moisture content, crude protein and 
crude fat were achieved by red tilapia fed the lowest and 
highest levels of probiotic and the lowest level of amino 
yeast, respectively. These records were significantly 
(P≤0.05) higher than those of the other groups. The 
highest body moisture was achieved by non-injected fish 
fed the lowest level of probiotic, and this moisture differed 
(P≤0.05) significantly from that of DNA injected fish fed 
the lowest level of amino yeast and their control group, 
and that of non-injected fish fed the highest level of 
amino yeast and their control group. Moreover, the 
highest body protein contents were obtained by red 
tilapia injected with shark DNA and fed the highest level 
of probiotic and differ (P≤0.05) significantly from those of 
non-injected fish fed with  mixed  probiotic,  and  those  of  
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Table 3. Effect of shark DNA injection and different additive levels on body composition of red tilapia 
(Oreochromis sp.).    
 
Treatment Moisture Crude protein Crude fat 
At the start 73.87 13.56 5.28 
    
At the end 
Type of DNA (T)    
DNA 72.69±0.64 
b
 18.09± 0.72
a
 6.30±0.40
a
 
Non-DNA 73.47±0.92 
a
 17.24± 0.87
b
 6.20±0.29
b
 
    
Type of Additive (A)    
Control 72.02±0.78
e
 17.23±1.02
d
 6.17±0.06
bc
 
P1 74.02± 1.09
a
 17.51±0.66
c
 6.31±0.26
b
 
P2 73.63±0.69
b
 18.72±0.60
a
 6.26±0.72
b
 
A1 72.82±0.22
d
 18.17±0.32
b
 6.48±0.32
a
 
A2 72.76±0.33
d
 17.30±0.74
cd
 6.20±0.19
bc
 
P1+A1 73.21±0.27
c
 17.09±0.97
d
 6.10±0.30
c
 
    
Interactions T x A    
DNA x C 71.35±0.07
c
 18.11±0.06
ab
 6.17±0.08 
DNA x P1 73.08±0.11
abc
 16.94±0.17
ab
 6.09±0.03 
DNA x P2 73.03±0.04
abc
 19.23±0.11
a
 6.88±0.04 
DNA x A1 72.64±0.06
bc
 18.43±0.11
ab
 6.75±0.14 
DNA x A2 73.04±0.05
abc
 17.93±0.20
ab
 6.07±0.18 
DNA X P1+A1 72.98±0.03
abc
 17.92±0.23
ab
 5.84±0.08 
Non-DNA x C 72.70±0.09
bc
 16.34±0.08
b
 6.17±0.06 
Non-DNA x P1 74.95±0.21
a
 18.07±0.13
ab
 6.53±0.04 
Non-DNA x P2 74.23±0.06
ab
 18.02±0.10
ab
 5.64±0.10 
Non-DNA x A1 73.01±0.08
abc
 17.91±0.16
ab
 6.21±0.06 
Non-DNA x A2 72.48±0.04
bc
 16.66±0.04
ab
 6.32±0.08 
Non-DNA X P1+A1 73.44±0.06
abc
 16.26±0.06
b
 6.35±0.07 
 
Means having different superscripts within column in a main effect are significantly different (P≤0.05). 
P1 and P2, 0.3 and 0.5% of probiotic, respectively; A1 and A2, 0.5 and 1.0 % of amino yeast, respectively. 
 
 
 
amino yeast and their control (Table 3).  
Data presented in Table 4 show also that, feed intake, 
feed conversion ratio (FCR) and protein efficiency ratio 
(PER) had surpassed the red tilapia injected with shark 
DNA significantly (P≤0.05). The highest feed intake was 
achieved by red tilapia fed the highest level of amino 
yeast, but did not differ (P≤0.05) significantly from those 
of fish fed the lowest and the highest levels of probiotic 
and their control. The highest FCR was recorded by the 
control group, but did not differ (P≤0.05) significantly from 
that of fish fed the highest level of amino yeast. Red 
tilapia fed the lowest level of amino yeast show significant 
(P≤0.05) superiority of PER and PR%, but did not differ 
(P≤0.05) significantly from those of fish fed the lowest 
and the highest levels of probiotic. Moreover, the highest 
record of ER % was obtained by the red tilapia fed the 
lowest level of amino yeast, but did not differ (P≤0.05) 
significantly from that of fish fed the highest level of 
probiotic.   
DISCUSSION 
 
Red tilapia injected with shark DNA had significant 
(P≤0.05) superiority of growth performance, body com-
position and feed utilization compared with non-injected 
group. The improvement of growth performance, body 
composition and feed utilization in the present work may 
be explained by Hemieda et al. (2004); they reported the 
genetic investigation of Nile tilapia injected directly with 
shark DNA (into skeletal muscles). The concentrations of 
such DNA up to 40 µg/0.1 ml/fish probably activated 
gradually cell proliferation in modified muscle tissues. 
Also, the measurements of DNA content in the muscles 
of modified fish indicated that shark DNA may be acting 
as a mutagen and it had no carcinogenic effect. This is 
mostly responsible for the enhancement of the productive 
performance shown in the modified fish injected with 
foreign DNA. Moreover, Martinez et al. (2000) and Lu et 
al. (2002)  found  that  anabolic  stimulation  and  average  
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Table 4. Effect of shark DNA injection and different additive levels on feed utilization of red tilapia (Oreochromis sp.).    
 
Treatment Feed intake (g) FCR PER PR% ER% 
Type of DNA (T)      
DNA 19.18±2.47
a
 1.62±0.16
b
 2.60±0.25
a
 49.28±6.21 27.89±3.45 
Non-DNA 
 
17.63±1.76
b
 1.78±0.21
a
 2.37±0.27
b
 48.04±5.87 26.99±3.92 
Type of Additive (A)      
Control 18.62±1.67
ab
 1.97±0.21
a
 2.14±0.25
c
 41.21±4.57
c
 23.37±1.74
d
 
P1 19.48±0.95
a
 1.61±0.06
b
 2.59±0.11
ab
 49.49±3.72
ab
 28.06±2.11
bc
 
P2 19.27±3.77
a
 1.60±0.08
b
 2.61± 0.15
ab
 53.91±1.19
a
 29.46±1.23
ab
 
A1 16.34±0.74
c
 1.53±0.12
b
 2.75±0.24
a
 55.45±4.21
a
 32.43±3.29
a
 
A2 19.53±1.68
a
 1.78±0.13
ab
 2.35±0.21
bc
 44.88±3.55
bc
 25.11±2.00
cd
 
P1+A1 17.20±1.01
bc
 1.69±0.19
b
 2.50±0.32
ab
 47.04±2.98
bc
 26.21± 2.76
bcd
 
      
Interactions T x A      
DNA x C 17.95 ± 0.29 1.88 ± 0.07 2.22±0.11 40.37±2.56 22.73±1.23 
DNA x P1 19.83 ± 0.86 1.56 ± 0.02 2.67±0.05 52.61±0.54 29.87±0.40 
DNA x P2 22.91 ± 1.38 1.54 ± 0.02 2.71±0.05 53.45±0.62 28.59±0.47 
DNA x A1 16.94 ± 0.61 1.47 ± 0.07 2.84±0.18 56.17±3.83 32.43±0.21 
DNA x A2 20.88 ± 1.31 1.73 ± 0.15 2.43±0.30 44.09±5.32 25.34±3.10 
DNA X P1+A1 16.59 ± 0.98 1.52 ± 0.07 2.76±0.16 49.00±3.15 28.40±1.73 
Non-DNA x C 19.29 ± 2.08 2.01 ± 0.27 2.06±0.37 42.04±7.30 24.02±2.43 
Non-DNA x P1 19.13 ± 0.91 1.67 ± 0.00 2.51±0.08 46.38±1.53 26.26±0.51 
Non-DNA x P2 15.61 ± 0.03 1.67 ± 0.07 2.51±0.15 54.37±1.74 30.34±1.12 
Non-DNA x A1 15.75 ± 0.14 1.59 ± 0.14 2.65±0.33 54.73±6.05 32.43±5.69 
Non-DNA x A2 18.68 ± 0.51 1.83 ± 0.08 2.28±0.14 45.68±2.67 24.89±1.46 
Non-DNA X P1+A1 17.81 ± 0.56 1.87 ± 0.06 2.34±0.09 45.07±1.15 24.02±0.82 
 
Means having different superscripts within column in a main effect are significantly different (P≤0.05).  
P1 and P2, 0.3 and 0.5% of probiotic, respectively; A1 and A2, 0.5 and 1.0 % of amino yeast, respectively. 
Feed conversion ratio (FCR) = dry feed intake / gain. 
Protein efficiency ratio (PER) = gain / protein intake. 
Protein retention (PR%) = protein increment / protein intake (100). 
Energy retention (ER %) = energy increment / energy intake (100). 
 
 
 
protein synthesis were higher in transgenic than that of 
non-transgenic fish. The results of the present study are 
consistent with these findings.  
The results obtained by El-Zaeem (2004), El-Zaeem 
and Assem (2004), Hemeida et al. (2004) and Assem 
and El-Zaeem (2005) showed that the dose of 40 µg/0.1 
ml/fish of shark DNA was more effective in stimulating 
most growth performance, body composition and 
immunity traits of O. niloticus and T. zillii. These traits 
were significantly higher (P≤0.05) than those of the other 
injected doses of DNA and their control. El-Zaeem (2012) 
produced grey mullet, Mugil cephalus with accelerated 
growth through direct injection of foreign DNA isolated 
from the liver of shark (Squalus acanthias L.) or African 
catfish (Clarias gariepinus) into muscles of fingerlings fish 
at the dose of 40 µg/fish. The results showed a significant 
(P≤0.05) improvement in most of the growth performance 
and body composition parameters of grey mullet 
fingerlings injected with shark DNA compared to both 
grey mullet injected with catfish DNA and the control  fish. 
While the results of FCR and PER indicated that fish 
injected with shark DNA or catfish DNA had significant 
(P≤0.05) superiority compared to their control. El-Zaeem 
et al. (2012) stated that dietary protein can be spared 
down to 22% protein by direct injection of shark DNA into 
skeletal muscles of red tilapia. Thus, feed costs can be 
reduced by a further reduction in dietary protein. The 
results of the present work are consistent of these 
findings.  
In addition, the different levels of probiotic and amino 
yeast were more effective in stimulating most of the 
productive performance traits compared to the control 
group and the mixed of probiotic and amino yeast. These 
results are consistent with the findings reported by El-
Tawil et al. (2012) in Mugil cephalus; Amer and El-Tawil 
(2011) in red tilapia; Li and Gatlin (2004) in hybrid striped 
bass, Morone chrysops × M. saxatilis; Essa et al. (2010) 
in O. niloticus and Abdel-Tawwab et al. (2010) in 
Sarotherodon galilaeus. These stimulation may be due to 
improvement in intestinal microbial flora balance which  in  
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turn will lead to better nutrient digestibility, higher adsor-
ption quality and increased enzyme activities (Waché et 
al., 2006; Suzer et al., 2008; Sáenz de Rodriganez et al., 
2009). 
The result of the present study indicates a possible 
easy and rapid way for improving red tilapia 
(Oreochromis sp.) characteristics. 
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